13D/13G Filings - Design Therapeutics Inc. (DSGN)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-02-07
4:16 pm
Unchanged
2024-12-31 13G Design Therapeutics, Inc.
DSGN
Star Irrevocable Trust #1 dated April 22, 2019 3,834,355
6.900%
0
(Unchanged)
Filing
History
2025-02-07
4:15 pm
Unchanged
2024-12-31 13G Design Therapeutics, Inc.
DSGN
Light Irrevocable Trust #1 dated April 22, 2019 3,834,355
6.900%
0
(Unchanged)
Filing
History
2024-08-13
6:53 pm
Purchase
2024-08-09 13D Design Therapeutics, Inc.
DSGN
Logos Global Management LP 4,232,627
7.500%
1,420,126increase
(+50.49%)
Filing
History
2024-02-14
4:58 pm
Sale
2023-12-31 13G Design Therapeutics, Inc.
DSGN
Citadel Advisors LLC 1,834,854
3.300%
-1,036,413decrease
(-36.10%)
Filing
History
2024-02-14
3:01 pm
Sale
2023-12-31 13G Constellation Pharmaceuticals, Inc.
CNST
Cormorant Asset Management LP 0
0.000%
-5,150,000decrease
(Position Closed)
Filing
History
2024-01-23
10:34 am
Sale
2023-12-31 13G Design Therapeutics, Inc.
DSGN
STATE STREET CORP
STT
695,224
1.240%
-2,342,236decrease
(-77.11%)
Filing
History
2023-11-14
5:00 pm
Sale
2023-11-14 13G Design Therapeutics, Inc.
DSGN
RA Capital Management, L.P. 0
0.000%
-2,971,231decrease
(Position Closed)
Filing
History
2023-09-07
09:38 am
Sale
2023-08-31 13G Design Therapeutics, Inc.
DSGN
BLACKROCK INC
BLK
2,394,544
4.300%
-1,113,480decrease
(-31.74%)
Filing
History
2023-04-03
4:55 pm
Purchase
2023-03-23 13G Design Therapeutics, Inc.
DSGN
Citadel Advisors LLC 2,871,267
5.100%
203,037increase
(+7.61%)
Filing
History
2023-02-14
3:14 pm
Sale
2022-12-31 13G Constellation Pharmaceuticals, Inc.
CNST
Cormorant Asset Management LP 5,150,000
9.210%
-290,451decrease
(-5.34%)
Filing
History
2023-02-14
08:14 am
Sale
2022-12-31 13G Design Therapeutics, Inc.
DSGN
Citadel Advisors LLC 2,668,230
4.800%
-40,017decrease
(-1.48%)
Filing
History
2023-02-08
1:03 pm
Purchase
2022-12-31 13G Design Therapeutics, Inc.
DSGN
STATE STREET CORP
STT
3,037,460
5.430%
3,037,460increase
(New Position)
Filing
History
2023-02-03
12:10 pm
Purchase
2022-12-31 13G Design Therapeutics, Inc.
DSGN
BLACKROCK INC
BLK
3,508,024
6.300%
3,508,024increase
(New Position)
Filing
History
2022-12-22
4:25 pm
Purchase
2022-12-19 13D Design Therapeutics, Inc.
DSGN
SR One Capital Fund I Aggregator LP 6,550,226
11.710%
908,750increase
(+16.11%)
Filing
History
2022-12-22
4:01 pm
Purchase
2022-12-12 13G Design Therapeutics, Inc.
DSGN
Citadel Advisors LLC 2,708,247
4.800%
2,708,247increase
(New Position)
Filing
History
2022-10-13
4:30 pm
Purchase
2022-10-03 13G Design Therapeutics, Inc.
DSGN
RA Capital Management, L.P. 2,971,231
5.320%
2,971,231increase
(New Position)
Filing
History
2022-03-31
4:23 pm
Purchase
2022-03-21 13D Design Therapeutics, Inc.
DSGN
Logos Global Management LP 2,812,501
5.000%
2,812,501increase
(New Position)
Filing
History
2022-02-14
3:08 pm
Purchase
2021-12-31 13G Constellation Pharmaceuticals, Inc.
CNST
Cormorant Asset Management LP 5,440,451
9.770%
325,607increase
(+6.37%)
Filing
History
2022-02-09
4:32 pm
Purchase
2021-12-31 13G Design Therapeutics, Inc.
DSGN
Ansari Aseem Z. 7,668,711
13.800%
7,668,711increase
(New Position)
Filing
History
2022-02-09
4:30 pm
Purchase
2021-12-31 13G Design Therapeutics, Inc.
DSGN
Light Irrevocable Trust #1 dated April 22, 2019 3,834,355
6.900%
3,834,355increase
(New Position)
Filing
History
Goto 0, 1, Next